Jiangsu Hualan Stock Hits Day Low of CNY 80.50 Amid Price Pressure

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. experienced a significant decline today, with the stock dropping by 7.51% and reaching an intraday low of CNY 80.50. This performance stands in contrast to the China Shanghai Composite, which fell by 3.63% on the same day. Over the past week, Jiangsu Hualan's stock has decreased by 4.22%, while its monthly performance shows a modest increase of 2.19%. However, the company has demonstrated remarkable growth over the past year, with a staggering 263.72% increase, significantly outperforming the Shanghai Composite's 13.33% rise. Despite these impressive annual figures, the company faces challenges in management efficiency, reflected in a low Return on Capital Employed (ROCE) of 9.64%. Additionally, the company has reported negative results for three consecutive quarters, with a notable decline in net sales of 4.72%. The stock's high P/E ratio of 151.00 and a low return on equity of 1.90% further highlight the financial pressures the company is currently navigating.